Lantern Pharma Inc (LTRN)
6.35
-0.55
(-7.97%)
USD |
NASDAQ |
May 07, 16:00
6.35
0.00 (0.00%)
After-Hours: 17:57
Lantern Pharma Shareholders Equity (Quarterly): 40.91M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 40.91M |
| September 30, 2023 | 45.41M |
| June 30, 2023 | 48.26M |
| March 31, 2023 | 52.58M |
| December 31, 2022 | 56.04M |
| September 30, 2022 | 59.03M |
| June 30, 2022 | 61.08M |
| March 31, 2022 | 65.32M |
| December 31, 2021 | 71.57M |
| Date | Value |
|---|---|
| September 30, 2021 | 75.73M |
| June 30, 2021 | 79.61M |
| March 31, 2021 | 81.73M |
| December 31, 2020 | 19.70M |
| September 30, 2020 | 21.57M |
| June 30, 2020 | 23.23M |
| March 31, 2020 | 0.5365M |
| December 31, 2019 | 0.9433M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.5365M
Minimum
Mar 2020
81.73M
Maximum
Mar 2021
47.25M
Average
52.58M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Eyenovia Inc | 8.999M |
| Cassava Sciences Inc | 137.47M |
| Alpine Immune Sciences Inc | 327.94M |
| Clearside Biomedical Inc | -15.91M |
| Poseida Therapeutics Inc | 103.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.65M |
| Total Liabilities (Quarterly) | 2.740M |